236
Participants
Start Date
February 14, 2020
Primary Completion Date
October 31, 2026
Study Completion Date
December 31, 2028
Allopurinol
Allopurinol powder for solution for infusion (PFI) 20 mg/kg body weight per administration will be administered early postnatally (within 45 minutes and 12 hours after the first dose), preoperatively (12 hours before surgery), intraoperatively (during surgery) and postoperatively (24 hours after surgery) to the neonate in case of a prenatal CCHD diagnosis. Allopurinol PFI will be administered only pre-, intra- and postoperatively to the neonate in case of a postnatal CCHD diagnosis.
Mannitol
Mannitol powder for solution (PFI) placebo will be administered early postnatally (within 45 minutes and 12 hours after birth), preoperatively (12 hours before surgery), intraoperatively (during surgery), and postoperatively (24 hours after surgery) to the neonate in case of a prenatal CCHD diagnosis. Mannitol PFI-placebo will be administered only pre-, intra- and postoperatively to the neonate in case of a postnatal CCHD diagnosis.
RECRUITING
University Medical Center Groningen (UMCG), Groningen
ACTIVE_NOT_RECRUITING
Radboud University Medical Center Nijmegen (Radboudumc), Nijmegen
RECRUITING
Erasmus Medical Center Rotterdam (Erasmus MC), Rotterdam
RECRUITING
University Medical Center Utrecht (UMC Utrecht), Utrecht
Collaborators (2)
ZonMw: The Netherlands Organisation for Health Research and Development
OTHER
University Medical Center Groningen
OTHER
Erasmus Medical Center
OTHER
University Medical Center Nijmegen
OTHER
ACE Pharmaceuticals BV
OTHER
dr. M.J.N.L. Benders
OTHER